# Axena Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/axena-health

- Industry: Medical Devices & Equipment
- Headquarters: Newton, US
- Website: www.axenahealth.com
- Total disclosed funding: $34M
- Latest round: Series A (Jun 4, 2024)
- Investors on record: 5

## About

Based in Massachusetts, US, and founded in 2023, Axena Health, Inc. operates as a medical device company. In February 2025, Axena Health, Inc. raised an undisclosed amount of venture funding from new investor Mayo Clinic. As of 2023, the company’s CEO is Eileen Maus. Axena Health’s product line includes the Leva® Pelvic Health System, which is medical equipment used for the treatment of women’s pelvic floor disorders. The company provides various drug-free treatments, including urinary incontinence (UI) treatment and chronic fecal incontinence (FI) treatment. The device is put into the vagina, and once movement is detected by its sensors, the user receives visual feedback on their smartphone. The company plans to use the funds raised in February 2025 to advance women’s pelvic health, opening the door to future innovations, educational initiatives, and evidence-based treatments.

## Funding rounds

- Series A, Jun 4, 2024, $9.4M — AXA IM Alts, KOFA Healthcare Investments, Avestria Ventures, Cross-Border Impact Ventures
- Series A, Feb 16, 2023, $25M — AXA Investment Managers

## Investors

- AXA Investment Managers — Series A
- AXA IM Alts — Series A
- KOFA Healthcare Investments (https://capitalatlas.ai/funds/kofa-healthcare-investments) — Series A
- Avestria Ventures (https://capitalatlas.ai/funds/avestria-ventures) — Series A
- Cross-Border Impact Ventures (https://capitalatlas.ai/funds/cross-border-impact-ventures) — Series A